A high response rate with a single drug in a phase I/II trial of pediatric brain tumor has set the stage for combination therapy with higher response and lower toxicity, researchers report.

Source: High response rate in phase I/II pe...apy with higher response, lower toxicity


David Cottle

UBB Owner & Administrator